Kooth to provide mental health services through its Soluna platform for up to 100,000 students: London Saturday, January 24, 2026, 18:00 Hrs [IST] Kooth, a global leader in digita ...
Avacta Therapeutics, a clinical stage biopharmaceutical company developing pre|CISION, a tumour-activated oncology delivery platform, has announced the US Food and Drug Administration (FDA) clearance ...
Truvian Health receives US FDA clearance for CBC on its TruVerus multi-modal blood testing system: San Diego Saturday, January 24, 2026, 16:00 Hrs [IST] Truvian Health, a diagnost ...
Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis: Seattle Saturday, January 24, 2026, 15:00 Hrs [IST] Parse Biosciences, the leading provider ...
Alivira Animal Health Limited (a wholly owned subsidiary of Viyash Scientific Limited) has entered into a partnership agreement with Boehringer Ingelheim India Private Limited for the distribution and ...
IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of Niemann-Pick Type C disease: Austin, Texas Saturday, January 24, 2026, 14:00 Hrs [IST] I ...
Ionis Pharma & Otsuka’s donidalorsen gets approval in European Union for hereditary angioedema: Carlsbad, California Saturday, January 24, 2026, 13:00 Hrs [IST] Ionis Pharmaceut ...
Pangea Laboratory collaborates with Gene Solutions to advance cancer diagnostics in United States: Irvine, California Saturday, January 24, 2026, 12:00 Hrs [IST] Pangea Laboratory ...
Hongene Biotech receives grant from Gates Foundation to develop and expand global access to mRNA vaccine raw materials: Singapore Saturday, January 24, 2026, 11:00 Hrs [IST] Honge ...
Novo Medi Sciences launches Nexipox Plus, a next-generation varicella vaccine built on advanced formulation: Our Bureau, Mumbai Saturday, January 24, 2026, 10:30 Hrs [IST] Novo Me ...
Sanofi's amlitelimab confirms its potential in atopic dermatitis: Paris Saturday, January 24, 2026, 10:00 Hrs [IST] Following the positive COAST 1 (clinical study identifier: NCT0 ...
China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma: London, UK Saturday, January 24, 2026, 09:00 Hrs [IST] GSK plc announced that China’s Nat ...